An observational study in Cardiovascular Disease, sponsored by Universitätsmedizin Mannheim. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-08-04.
Sponsored by Universitätsmedizin Mannheim · Observational
Electrical velocimetry (EV) is one of the latest adaptions of impedance cardiography showing diverging results. With electrode position being a suspected factor influencing measurement accuracy or reproducibility for impedance cardiography in general, no data is currently available on altering the gap of the two lower electrodes in EV. Reference values were determined using the non-invasive gold-standard cardiac magnetic resonance imaging (CMR).
4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.
This study's enrollment of 92 is below the median of 573 across 1,485 observational studies indexed under Cardiovascular Diseases.
Browse Cardiovascular Diseases studies →Universitätsmedizin Mannheim is the lead sponsor of 75 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients undergoing CMR
Exclusion Criteria:
Assessment of hemodynamic function using: * CMR * EV with an inter-electrode gap (lower pair) of 5 cm * EV with an inter-electrode gap (lower pair) of 15 cm
difference between CMR and EV cardiac output measurements
Time frame: 45 minutes
difference between two consecutive EV cardiac output measurements
Time frame: 5 minutes
This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitätsmedizin Mannheim